0001127602-23-014739.txt : 20230505
0001127602-23-014739.hdr.sgml : 20230505
20230505165407
ACCESSION NUMBER: 0001127602-23-014739
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230503
FILED AS OF DATE: 20230505
DATE AS OF CHANGE: 20230505
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Karachun Rita A
CENTRAL INDEX KEY: 0001601572
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06571
FILM NUMBER: 23894712
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merck & Co., Inc.
CENTRAL INDEX KEY: 0000310158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 221918501
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
BUSINESS PHONE: 908-740-4000
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
FORMER COMPANY:
FORMER CONFORMED NAME: Merck & Co. Inc.
DATE OF NAME CHANGE: 20091103
FORMER COMPANY:
FORMER CONFORMED NAME: SCHERING PLOUGH CORP
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0407
4
2023-05-03
0000310158
Merck & Co., Inc.
MRK
0001601572
Karachun Rita A
MERCK & CO., INC.
126 EAST LINCOLN AVENUE
RAHWAY
NJ
07065
1
Sr. VP Fince-Global Controller
0
Common Stock
2023-05-03
4
M
0
803
117.89
A
45362.972
D
Common Stock
2023-05-03
4
F
0
276
117.89
D
45086.972
D
Common Stock
2023-05-04
4
M
0
949
118.22
A
46035.972
D
Common Stock
2023-05-04
4
F
0
326
118.22
D
45709.972
D
Common Stock
2023-05-04
4
M
0
15875
62.07
A
61584.972
D
Common Stock
2023-05-04
4
S
0
15875
117.5334
D
45709.972
D
Restricted Stock Unit
2023-05-03
4
M
0
803
0
D
2023-05-03
2025-05-03
Common Stock
803
1608
D
Restricted Stock Unit
2023-05-04
4
M
0
949
0
D
2022-05-04
2024-05-04
Common Stock
949
951
D
Stock Option (Right to Buy)
62.07
2023-05-04
4
M
0
15875
0
D
2018-05-05
2027-05-04
Common Stock
15875
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.5000 to $117.6200, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.
These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
The option became exercisable in equal installments on 5/5/2018, 5/5/2019 and 5/5/2020.
/s/ Kelly E. W. Grez as Attorney-in-Fact for Rita Karachun
2023-05-05